CJ teams up with Japanese biopharmaceutical firm

Published: 2010-06-10 06:57:00

Updated: 2010-06-10 06:57:00

CJ CheilJedang Corporation signed an agreement with RaQuaria Co. on July 7, a promising biopharmaceutical company in Japan for the development of new antiulcer drugs.

“The two companies would jointly invest a sizable money in theresearch and development (R&D) program to acquire technologies ne...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK